S0106B Studying Bone Marrow Samples From Women With Acute Myeloid Leukemia
NCT01575535 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2015-03-06
Summary
RATIONALE: Studying samples of bone marrow from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer.
PURPOSE: This research trial studies bone marrow samples from women with acute myeloid leukemia.
Conditions
Interventions
- GENETIC
-
gene expression analysis
- OTHER
-
flow cytometry
- OTHER
-
fluorescence activated cell sorting
- OTHER
-
laboratory biomarker analysis
- OTHER
-
medical chart review
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
SWOG Cancer Research Network
lead NETWORK
Principal Investigators
-
Roland Walter, MD, PhD · Fred Hutchinson Cancer Center
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-04-30
- Primary Completion
- 2012-05-31
- Completion
- 2012-05-31
More Related Trials
-
Studying Samples From Patients With T-Cell Acute Lymphoblastic Leukemia
NCT01581528 ·Status: COMPLETED
-
Studying DNA in Blood and Bone Marrow Samples From Younger Patients With Acute Myeloid Leukemia
NCT01024127 ·Status: COMPLETED
-
Biomarkers in Bone Marrow Samples From Pediatric Patients With High-Risk Acute Myeloid Leukemia
NCT01076569 ·Status: COMPLETED
-
S0125, Chemotherapy, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Older Patients With Acute Myeloid Leukemia
NCT00053014 ·Status: TERMINATED ·Phase: PHASE2
-
Pharmacological Study of Intravenous OTS167 in Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Advanced Myelodysplastic Syndromes, Advanced Myeloproliferative Neoplastic Disorders, or Advanced Chronic Myelogenous Leukemia
NCT02795520 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
S0106 Cytarabine and Daunorubicin w/ or w/o Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AML
NCT00085709 ·Status: COMPLETED ·Phase: PHASE3
-
Refining the Role of Mid-induction Bone Marrow Biopsy in Acute Myeloid Leukemia: A Pilot Study
NCT06323590 ·Status: ACTIVE_NOT_RECRUITING
-
Prognostic Biomarkers in Samples From Young Patients With Acute Myeloid Leukemia
NCT01245231 ·Status: COMPLETED
-
Collection and Banking of Leukemia Cells MDS/AML
NCT00809367 ·Status: COMPLETED ·Phase: NA
-
Combination Chemotherapy Followed by Melphalan and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Acute Myeloid Leukemia
NCT00004056 ·Status: COMPLETED ·Phase: PHASE1
-
Sorafenib Tosylate Before and After Donor Bone Marrow Transplant in Treating Patients With Acute Myeloid Leukemia
NCT01578109 ·Status: COMPLETED ·Phase: PHASE1
-
Immunochemotherapy and AlloSCT in Patients With High Risk CD33+ AML/MDS
NCT02221310 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia
NCT00002549 ·Status: UNKNOWN ·Phase: PHASE3
-
Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia
NCT00002658 ·Status: UNKNOWN ·Phase: PHASE3
-
Donor Stem Cell Transplant in Treating Patients With High Risk Acute Myeloid Leukemia
NCT01801046 ·Status: TERMINATED ·Phase: PHASE1
-
Acute Myeloid Leukemia and Markers of Leukemia Stem Cells (CLL1 and CD45RA)
NCT06297551 ·Status: RECRUITING
-
Autologous Bone Marrow Transplantation in Acute Non-Lymphoblastic Leukemia During First or Subsequent Remission
NCT00186381 ·Status: COMPLETED ·Phase: PHASE2
-
Gemtuzumab Ozogamicin With or Without Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia
NCT00006122 ·Status: COMPLETED ·Phase: PHASE2
-
Biomarkers in Blood Samples From Patients With Acute Myeloid Leukemia
NCT01385150 ·Status: COMPLETED
-
Using Multiparametric Flow Cytometry to Detect Peripheral Blood and Bone Marrow Leukaemia Stem Cells for Relapse Prediction in P-AML
NCT06452732 ·Status: RECRUITING
-
S0112 Cytarabine and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia
NCT00023777 ·Status: COMPLETED ·Phase: PHASE2
-
Allogeneic SCT for CML, TKI Failure After TKI Failure
NCT02172365 ·Status: UNKNOWN
-
S0117 Gemtuzumab Ozogamicin Plus Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia
NCT00049179 ·Status: COMPLETED ·Phase: PHASE2
-
AML Therapy With Irradiated Allogeneic Cells
NCT02105116 ·Status: TERMINATED ·Phase: NA
-
Geriatric Optimization Plan to Improve Survival in Older Adult Allogeneic Hematopoietic Cell Transplant Candidates, OTIS Study
NCT05972577 ·Status: COMPLETED ·Phase: NA